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The purpose of this study is to clarify a relations hip between 
bullous pemphigoid autoantibodies against two major 
BP antigens, 230 kilodalton (kD) (BPAG 1) and 180 kD 
(BPAG2) and their binding sites, using immunoblot analysis 
and indirect immunofluorescence on salt-split skin. Of the 
135 sera obtained from patients in whom bullous pemphi-
goid had previously been diagnosed by clinical and immuno· 
pathologic criteria, all 52 sera recognizing only BPAG 1 
stained only the epidermal side of split skin (epidermal pat-
tern) . Of 24 sera recognizing only BPAG2, 20 showed the 
epidermal pattern and four stained both the epidermal and 
dermal sides (combined pattern). of 42 recognizing both 
BPAGl and BPAG2, 35 showed the epidermal pattern and 
seven showed the combined pattern. Of 17 that reacted with 
neither antigen, nine showed the epidermal pattern, four 
showed the combined pattern, and four stained only the der-
Bullous pemphigoid (BP) is an autoimmune blistering disorder with autoantibod ies against the basement membrane zone (BMZ) of stratified squamous epithe-lium. Recent studies [1 ,2] have demonstrated that BP antigens are heterogeneous and consist of two major 
antigens with molecular weights of 230 (kilodaltons) kD (BPAG 1) 
[3 -5] and 180 kD (BPAG2) [2,6-18]. The ultrastructurallocaliza-
tion of BP antigens has been studied by the immunoelectron micro-
scopic technique. Although early studies revealed that the BP anti-
gen was localized within the lamina lucida of the BMZ [18,19], 
later studies have shown that it is associated with hemidesmosomes 
[7 ,20 - 23]. W e recently found that monoclonal and polyclonal au-
toantibodies against BPAG 1 bound only to the intracellular domain 
of hemidesmosomes [24-27] , whereas autoantibodies against 
BPAG2 bound along the plasma membrane of the hemidesmosome 
complex [27]. 
When human skin is incubated with 1 M NaCI, the BMZ is 
separated at the lamina lucida, leaving the BP anti gen on the epider-
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mal side (dermal pattern). Two of the four cases that showed 
a dermal pattern were retrospectively identified as epidermo-
lysis bullosa acquisita. Immunoelectron microscopy con-
firmed that a serum with combined pattern bound to both 
intracellular and extracellular sites of hemidesmosomes. 
Our results suggest that autoantibodies that react solely 
with BPAG 1 bind exclusively to the epidermal side of salt-
split skin and never show either a combined or a dermal 
pattern, and that most antibodies against BPAG2 bind to the 
epidermal side. The combined pattern suggests the presence 
of autoantibodies against the extracellular epitopes of 
BPAG2 that are separated from. the epidermis during the 
salt-splitting process . Key words: imm~moelectro'1 microscopyj 
immunoblotjimmunojhlOrescencejextraceliular epitope. ] Invest 
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mal side [28]. In an indirect immunofluorescent study of 1 M 
N aCI-split skin, Gammon et al [29] found that 36 of 45 BP serum 
samples showed binding only to the epidermal side (epidermal 
pattern) of split skin, nine showed binding to both epidermal 
and dermal sides (combined pattern), and six showed binding only 
to the dermal side (dermal pattern) . Indirect immunoelectron 
microscopy showed that sera with antibodies that showed epider-
mal and combined patterns reacted with the lamina lucida; sera 
that showed a dermal pattern reacted with the sublamina densa 
region [29]. Logan et at [30] found that 212 of 228 BP sera 
showed an epidermal pattern, seven showed a combined pat-
tern, and nine sera, which were later found to be epidermolysis 
bullosa acquisita (EBA), showed a dermal pattern. In a study by 
Niimi et 01 [15]. 173 of 185 BP sera had an epidermal pattern, six 
had a combined pattern, and six had a dermal pattern. Immuno-
blot analysis of the six sera with the combined pattern showed 
that four reacted exclusively with BPAG2 in epidermal extracts, 
one reacted with both BPAGl and BPAG2, and one showed no 
specific reactivity in either epidermal or dermal extracts. To date, 
however, there has been no indirect immunofluorescent study of 
1 M NaCI-split skin using a large number ofBP serum samples for 
which the antigen profil.:s have been determined by immunoblot 
analysis. 
The purpose of this study is to clarify the relationship between BP 
autoantibodies against BPAGl and/or BPAG2 and their binding 
sites on 1 M NaCI-split skin using serum characterized by immu-
noblot analysis. W e also attempted to elucidate the ultrastructural 
localization of the dermal epitopes of BP antigens. 
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Figure 1. Demonstration of antibody binding to BP antigens. Immunobl~t 
analysis of epidermal extracts was performed wIth sera from patients chlll-
cally and immunopathologically diagnosed as BP (la/J es 1- 7) and normal 
human serum (lalle 8). 
MATERIALS AND METHODS 
BP Sera We obtained sera from 135 patients in whom BP had previously 
been diagnosed. T he selection criteria were 1) clinical symptoms compatible 
with BP and 2) positive direct and indirect immunofluorescent evidence of 
immunoglobulin (Ig)G at the BMZ. All patients had circulating IgG class 
anti-BMZ antibodies titers above 1: 40, determined by standard indirect 
immunofl uorescence. Serum samples were obtained from 20 normal volun-
teers, three individuals with pemphigus vulgaris, and three individuals with 
EBA to serve as controls. 
hnmunoblot Analysis ofEpidennal Extracts Immunoblot analysis of 
epidermal extracts was performed as described previously [2]. In brief, pro-
teins were extracted from the epidermis of human foreskin and separated by 
sodium dodecylsulfate-polyacrylamide gcl electrophoresis (SDS-PAGE). 
They were then electrophoretically transferred to a nitrocellu lose sheet. The 
sheet was cut into strips and incubated with patients' sera diluted 1 : 40 and 
then with peroxidase-conjugated rabbit anti-human IgG (DAKO, Copen-
hagen, Denmark). Reaction products were developed with 0.05% 4-chloro-
1-naphthol in the presence of 0.05% H20 2 • 
Indirect Immunofluorescence on 1 M NaCI-Split Normal Human 
Skin Normal human skin was obtained from two individuals at surgery 
and split by the method described by Gammon e/ al [29]. Briefly, the skin was 
cut into 1-cm2 pieces and incubated in 1 M NaCI for 48 h at 4°C with 
continuous agitation. The epidermis was gently dislodged from the dermis, 
mounted in OCT compound and 4-Jlm sections were made with a cryostat 
(International Equipment Co., Needham, MA). The level of the split was 
confirmed by an indirect immunofluorescent antigen-mapping study. Type 
VII collagen and type IV collagen were identified on the dermal side of the 
split skin. Human monoclonal antibodies against epitope ofBPAG1 [2,24] 
reacted with the epidermal side. 
All 135 serum samples were studied by indirect immunofluorescence 
using this split skin as a substrate. Briefly, the split-skin specimens were 
incubated with 1: 10 dilutions of patients' sera and then with fluorescein-
conjugated anti-human IgG (DAKO). The slides were read independently 
by three dermatopathologists. Staining patterns were classified as epidermal, 
dermal, or combined. 
Pre-Embedding Indirect Immunoelectron Microscopy on 1 M 
NaC I-Split Normal Human Skin Pre-embedding immunoperoxi-
clase elecfron microscopy using 1 M NaCI-spl it skin as a substrate was per-
230- AND 180-kD BP ANTIGENS IN SALT-SPLIT SKIN 687 
Table I. Immunoblot Analysis Using Epidermal Extracts and 
Indirect Immunofluorescence on 1 M NaCI-Split Skin of 135 
Patients' Sera Diagnosed as BP 
Immunoblot 
Reactivity 
230 kD (+) 
180 kD (-) 
230 kD (-) 
180 kD (+) 
230 kD (+) 
180 kD (+) 
230 kD (-) 
180 kD (-) 
Total 
Immunofluorescent Staining Patterns 
on 1 M N aCl-Split Skin 
Epidermal Combined Dermal 
Pattern Pattern Pattern 
52 0 0 
20 4 0 
35 7 0 
9 4 4' 
116 15 4 
Total 
52 
24 
42 
17 
135 
• Two of 4 sera with a dermal pattern were retrospectively identified as EBA. 
formed as described previonsly [22]. Briefly, fresh frozen sections (6 Jlm) 
of 1 M NaCI-split normal human skin were incubated with 1 : 40 diluted 
BP serum that showed a typical combined pattern and recognized only 
BPAG2. 
Specimens were incubated with 1 : 40 diluted peroxidase-conjugated rab-
bit anti-human IgG (DAKO). Then they were pre-fixed with 2% glutaral-
dehyde, reacted with 3,3' -diamino benzidine solution, post-fixed with 1 % 
osmium tetroxide, dehydrated with graded ethanol, and embedded in epon 
812 using the inverted capsule method. Ultrathin sections were cut and 
observed under a transmission electron microscope (JEOL 1200 EX) with-
out counterstaining. 
Immunoblot Analysis of Dermal Extracts Immunoblot assay of der-
mal extracts was performed for the nine BP sera that showed the epidermal 
pattern on Immunofluorescent analysis of split skin but did not show any 
reactivity on immunoblot analysis of epidermal extracts and for 19 BP sera 
with either the combined pattern or the dermal pattern. 
Dermal extracts were prepared by the method described by Woodley el al 
[31 ], with some modification. Briefly, human foreskin was floated in 1 M 
NaCI for 48 h at 4 °C. Afterthe epidermis was removed, the dermal portion 
was vortexed for 60 min at room temperature in 12.5 mM Tris-HCI buffer, 
pH 7.0, containing 6 M urea, 2% SDS, 1 mM phenylmethylsulfonyl fluo-
ride (PMSF), 2 mM ethylenediamine tetraacetic acid (EDTA), and 0.1 M 
dithiothreitol fo llowed by centrifugation at 10,000 X g for 80 min at 
18 °C. The supernatant was processed for immunoblot analysis as described 
above. 
Post-Embedding Immunogold Electron Microscopy on Normal 
Human Skin For post-embedding immunogold electron inicroscopy, 
the skin tissue was processed by rapid freezing and freeze substitution 
fixation without chemical fixatives, as described previously [23]. Briefly, 
small pieces of fresh normal human skin were rapidly frozen in liquid 
propane (-190 °C), cryosubstituted, and then embedded in Lowicryl 
K11M (Chemische Werke Lowe, Waldkraiberg, Germany) at -60°C. 
The specimens were polymerized with ultraviolet (UV) radiation. Ultra-
thin sections were cut and incubated overnight at 4°C with 1: 40 diluted BP 
serum that showed a typical combined pattern and recognized only 
BPAG2. Specimens were placed on a drop of 1 : 60-diluted 5 nm gold-
labeled goat anti-human IgG (H + L) (Amersham International pic, 
Buckinghamshire, UK) at room temperature for 2 h and subsequently incu-
bated with an immunogold silver enhancement solution (Amersham Inter-
national pic) at 4 ° C for 3 min. Specimens were counterstained with uranyl 
acetate and lead citrate and observed under a transmission electron micro-
scope. 
RESULTS 
Immunoblot Analysis of Epidermal Extracts Of 135 BP 
serum samples, 52 (38%) recognized only BPAG1 in epidermal 
extracts, 24 (18%) recognized only BPAG2, 42 (31%) recognized 
both BPAG1 and BPAG2, and 17 (13%) reacted with neither anti-
gen. N one of the control sera reacted with these two proteins (Fig 1, 
Table I) . 
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Figure 2. Indirect immunofluorescence on 1 M NaCI-split skin. Normal 
human skin was incubated in 1 M NaCI for 48 h at 4 'C and the split was 
made between the epidermis and the dennis. Cryosections of this split skin 
were incubated with sera from patients diagnosed as BP. a) Sera produced 
linear staining along the epidermal side on the split skin. b) Sera produced 
linear staining along the dermal side. c) Sera produced linear staining along 
both epidermal and dermal sides. 
Localization ofBP Antigens on 1 M NaCI-Split Skin Bind-
ing patterns were consistent in split-skin samples obtained from 
both donors; the same resul ts were obtained by three observers in all 
experiments. Each serum produced a linear pattern of fluorescence 
on split skin, along the epidermal side (epidermal pattern; Fig 2a), 
along the dermal side (dermal pattern; Fig 2b), or on both the 
epidermal and dermal sides (combined pattern; Fig 2c). As 
shown in Table I, all 52 BP sera that recognized only BPAGl 
showed only the epidermal pattern. Of 24 BP sera that recognized 
only BPAG2, 20 (83%) showed the epidermal pattern, four 
(17%) showed the combined pattern, and none showed the der-
mal pattern. Of 42 BP sera that recognized both BPAGl and 
BPAG2, 35 (83%) showed the epidermal pattern, seven (17%) 
showed the combined pattern, and none showed the dermal pattern. 
Ofl7 BP sera that reacted with neither antigen, nine (52%) showed 
the epidermal pattern, four (24%) showed the combined pattern, 
and four (24%) showed the dermal pattern. Of the four that showed 
the dermal pattern, two were retrospectively found to be from 
patients with EBA. No specific fluorescent pattern was observed 
in the control sera, except for the EBA sera, which had a dermal 
pattern. 
Pre-Embedding Immunoelectron Microscopy on 1 M NaCl-
Split Skin The dermo-epidermal junction was separated at the 
lamina lucida, with the plasma membrane of the basal cells on the 
roof and the lamina densa on the floor. BP serum that showed a 
combined pattern and recognized only BPAG2 bound to both epi-
dermal and dermal sides in association with hemidesmosomes. Ag-
gregates of diaminobenzidine (DAB) reaction products were also 
present on the fibrous components attached to the lamina densa in 
the separating space (Fig 3). 
Immunoblot Analysis of Dermal Extracts None of the 15 
sera that showed a combined pattern on the split skin reacted with a 
Figure 3. Ultrastructural localization of BP serum that showed a com-
bined pattern and recognized only BPAG2 by pre-embedding imll1uno-
electron microscopy. NaCI-split skin sections (1 M) were incubatea with 
the serum, which showed the combined pattern and recognized only 
BPAG2, and then with peroxidase-conjugated anti-human IgG. Specimens 
were reacted with DAB, embedded in epon, and cut into ultrathin sec-
tions. Asterisks, binding along both epidermal and dermal sides. ArrolV-
Ireads, fibrous components attached to the lamina densa. E: epidermis, 
0: dermis. 
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Figure 4. Immunoblot analysis of dermal extracts was performed with. the 
sera that showed the dermal pattern (lalles 1-4), serum from a patient 
diagnosed as EBA (10 lIe 5), and normal human sera (lalle 6). 
specific protein in dermal extra~ts . Of four ~era that showed ~ der-
mal pattern, two did not react With any protem but ':W0 rec<,>g11lzed a 
290-kD protein that corresponded to the EBA antigen .(Flg 4). Al-
though BP was originally diagnosed m these two patIents, re~ro­
spective re-examinat~on of their clinical featur~s confirmed a diag-
nosis of EBA. The nme sera that showed an epidermal pattern and 
reacted with neither antigen in epidermal extracts did not react with 
any specific protein in dermal extracts. 
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Post-Embedding Immunogold Electron Microscopy on 
Normal Human Skin Silver-enhanced gold particles immuno-
labeled with BP serum that showed a combined pattern and recog-
nized only BPAG2 were observed in both intracellular and extracel-
lular sites on the hemidesmosome area. Extracellular labelings were 
observed within 100 nm of the plasma membrane (Fig 5). 
DISCUSSION 
Using post-embedding immunogold electron microscopy, we dem-
onstrated recently that purified autoantibodies against BPAG 1 
bound only to the intracellular domain ofhemidesmosomes, which 
was located 40-140 nm from the plasma membrane [27]. In con-
trast, the purified autoantibodies against BPAG2 bound along the 
plasma membrane of the bemidesmosomes, which extended from 
an area 10 nm outside the cells to 50 nm inside the cells [27]. How-
ever, the relationship between BPAGl and BPAG2, two major BP 
antigens, and their localization in 1 M N aCI-split skin has not yet 
been clarified. 
In the present study, all 52 BP sera that recognized BPAGI but 
not BPAG2 showed only an epidermal pattern, suggesting that the 
anti-BPAG 1 antibodies were responsible for the epidermal pattern, 
which may correspond to the intracellular domain of hemidesmo-
some. The 11 BP sera that showed a combined pattern contained 
antibodies against BPAG2 suggesting that the anti-BPAG2 anti-
bodies were responsible for the combined pattern. Pre-embedding 
immunoelectron microscopic analysis of samples that exhibited a 
combined pattern showed reactivity on both epidermal and dermal 
sides of 1 M NaCI-split skin. In the intervening space, reactivity 
was also present in fibrous components attached to the lamina densa 
that were thought to represent components of the lamina lucida. 
Post-embedding immunogold electron microscopy using normal 
human skin revealed that BP serum with a combined pattern 
showed binding to both intracellular and extracellular sites of the 
hemidesmosome area. The labeling observed on the fibrous compo-
nents attached to the lamina densa may have corresponded to the 
extracellular epitope, which was 100 nm from the plasma mem-
brane. The localization of this extracellular epitope appears to differ 
from that of the BPAG2 epitope observed in a previous study [27], 
in which the BPAG2-specific BP serum and affinity-purified anti-
BPAG2 IgG reacted with a region much closer to the plasma mem-
brane. 
It is difficult to explain the combined pattern of staining seen in 
certain BP sera. Our results indicate that the combined pattern is 
related to the presence of anti-BPAG2 antibodies. BPAG2 has re-
cently been shown to consist of 15 repeated collagenous domains in 
its extracellular domain, with a potential transmembrane domain 
[17] . Hopkinson et al [32] identified intracytoplasmic epitopes of 
Figure 5. Ultrastructural 
localization oEBP serum that 
showed a combined pattern 
and recognized only BPAG2 
by post-embedding immu-
nogold electron microscopy. 
Frozen normal human skin 
specimens were cryosubsti-
cuted and embedded in Lo-
wicryl Kl1M and then 
polymerized. Ultrathin sec-
tions were cut, incubated 
with BP serum, and labeled 
with 5 11m gold. Bar, 
200 nm. 
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BPAG2; their findings also suggested that BPAG2 epitopes are 
heterogeneous. It is possible that the major epitopes ofBPAG2 are 
located on the epidermal side of split skin and that the serum sam-
ples that exhibited a combined pattern reacted with rel~tively minor 
epitopes of BPAG2 that were separated from their epidermal frag-
ment during the salt-splitting procedure and located on the dermal 
side. The possibility that some unknown antigens located on the 
dermal side of the split skin were responsible for the dermal staining 
cannot be ruled out. BPAG! and BPAG2 are not the only antigens 
associated with BP [8,13,32]; therefore, other autoantigens that lost 
their antigenicity on immunoblots may have existed in BP sera with 
a combined pattern. 
We retrospectively examined the clinical features of BP pa-
tients with autoantibodies that showed a combined pattern. All cases 
showed typical clinical features of BP in terms of age, distribu-
tion of skin lesions, response to treatments, and laboratory data. 
Although three patients showed mucous membrane involvement, 
none had scars, milia, or skin fragility suggesting either cicatri-
cial pemphigoid or EBA. The dermal pattern was observed in 
twO of four sera that recognized the 290-kD protein in dermal 
extracts. These two cases were retrospectively confirmed to have 
EBA. In the other two cases, neither BP nor EBA could be con-
firmed. 
In conclusion, our data suggest that all autoantibodies against 
BPAG1 and/or BPAG2 always bind to the epidermal side of 1 M 
NaCI-split skin and sometimes showed a combined pattern but 
never show only a dermal pattern. The combined pattern appeared 
to be associated with autoantibodies against extracellular epitopes of 
BPAG2 that were localized in the lamina lucida, approximately 
100 nm away from the plasma membrane. 
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